Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2022-03-01
Serie:Vaccines
Soggetti:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Accesso online:https://www.mdpi.com/2076-393X/10/4/492
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi